Harrison Clinical Research GmbH

Harrison Clinical Research
Albrechtstrasse 14
80636 Munich, Germany
Tel: 49-(0)89 - 12 66 80-0
Fax 49-(0)89 - 12 66 80-2444
Homepage: www.harrisonclinical.com

Efficacy studies

State-of-the-art services

To enlarge this photo, please click on it

The Clinical Pharmacology Unit (CPU) of Harrison Clinical Research has 6 intensive care beds and 30 beds for short-term stays (several days), of which 18 can be used for long-term stays (several weeks).

The unit performs state-of-the-art services in Phase I-IIa, from first administration to man, pharmacokinetics/pharmacodynamics, bioequivalence, special population and efficacy studies through to large out-patient  studies, for example, vaccination studies and food science studies.



Efficacy studies in:

  • hypo/hypertension
  • peripheral arterial occlusive disease
  • hepatic and renal failure
  • end-stage renal disease, with dialysis
  • hyperlipidaemia
  • diabetes mellitus both insulin dependant and independant
  • post-menopause
  • obesity
  • geriatrics
  • osteoarthritis/arthrosis
  • rheumatoid arthritis
  • low back pain
  • growth hormone deficiency
  • psoriasis
  • chronic obstructive pulmonary disease
  • allergic asthma, allergy, rhinitis
  • common infectious diseases

« back